IBMs, Billion

IBM's $10 Billion Quantum Wager and Pentagon Extension Form a Dual Strategy as Stock Rebounds

Published on 05/28/2026 at 17:43 | Redaktion boerse-global.de

IBM combines a $46 million government contract expansion with a $10 billion quantum computing push, sparking a 4% stock rise amid overbought conditions.

IBM's $10 Billion Quantum Wager and Pentagon Extension Form a Dual Strategy as Stock Rebounds Illustration mit AI erstellt übermittelt durch boerse-global.de
IBM's $10 Billion Quantum Wager and Pentagon Extension Form a Dual Strategy as Stock Rebounds Illustration mit AI erstellt übermittelt durch boerse-global.de

IBM is stitching together two very different kinds of growth this week: a long-running government consulting contract that just grew by $46 million, and a $10 billion industrial push into quantum computing that comes with a $1 billion check from the US government. The unlikely pairing is giving the stock a springboard after a rocky start to the year.

The Air Force District of Washington exercised the 26th modification of a contract originally signed in 2024, bringing its cumulative value to nearly $156 million. IBM will provide resource planning and civil engineering support, with work running through July 2029. Roughly $37 million of that total has already been obligated from the 2026 budget. Such stable, multi-year federal deals provide a counterweight to the lumpier revenue from IBM's cloud and AI businesses.

That stability is taking an even bigger form in Albany, New York. IBM has signed a memorandum of understanding with the US Commerce Department to build the "Anderon" foundry, a facility dedicated to quantum chip manufacturing on 300-millimeter wafers. The CHIPS Act is contributing $1 billion, and IBM is matching that with another $1 billion in cash plus intellectual property. The plant aims to shift quantum processors from laboratory oddities to industrial-scale production.

The target is 2029, when IBM expects to deploy its first large-scale, fault-tolerant quantum computer — a machine capable of correcting its own errors. If successful, the leap would unlock applications in financial modeling and cryptography, where even tiny computational errors can render results useless. IBM already operates more than 90 quantum systems worldwide and counts over 325 partners across industry, academia, and government.

Should investors sell immediately? Or is it worth buying IBM?

Alongside the hardware blitz, IBM's Red Hat unit is rolling out Project Lightwell, a $5 billion program to secure the open-source software supply chain using artificial intelligence. More than 20,000 engineers are tasked with finding and patching vulnerabilities in open-source packages. The plan is to turn the project into a subscription service within the next 30 days. Early adopters include Bank of America, JPMorgan Chase, Goldman Sachs, and Visa — a sign that financial institutions, with their low tolerance for software risk, see immediate value.

The twin announcements lit a fire under the stock. IBM shares rose 4.1% in early US trading after a pre-market gain of 1.7%. In Frankfurt, the stock hit €227.65, a daily increase of 2.94%. Over the past 30 days, IBM has climbed 14.40% in Germany — a sharp reversal from a difficult start to the year, with the stock still down 8.45% since January 1 and trading 2.24% below its 200-day moving average.

The rapid run-up has pushed the relative strength index to 84.5, firmly in overbought territory. That technical heat raises the question of whether the recent momentum can hold without a pullback.

IBM at a turning point? This analysis reveals what investors need to know now.

Analysts remain broadly optimistic but divided on the upside. RBC Capital rates IBM "Outperform" with a price target of $300, down from $330 earlier. Wedbush is more bullish at $320, while the TipRanks consensus sits at $290.

For the near term, the market will watch whether Project Lightwell converts its early banking clients into paying subscribers within the promised 30-day window. The bigger prize, however, remains the quantum odyssey. If IBM can deliver fault-tolerant computing by 2029, the company will have turned a long-term research bet into a commercial reality — and given investors a reason to look past the annual loss column.

Ad

IBM Stock: New Analysis - 28 May

Fresh IBM information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated IBM analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US4592001014 | IBMS | boerse | 69434563 |